Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease

Phase 1

Completed

• Conditions: Neurology; Immunology

• Registration Number: NCT06539260
• Lead Sponsor: Suzhou Municipal Hospital of Anhui Province

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-1
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - Meets the age requirement and is in good health.<br><br>Exclusion Criteria:<br><br> - Have related vitamin D metabolic diseases (kidney failure, severe liver damage,<br> hereditary 1a hydroxylase deficiency, etc.).<br><br> - Have an immune system disorder.<br><br> - Have a history of disabling cerebrovascular disease.<br><br> - Have a grade 1 or 2 relative with PD.<br><br> - Have severe dementia, depression, or serious mental illness.<br><br> - Failure to sign the informed consent form.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Th17;Treg;Vitamin D

Secondary Outcome Measures

Name	Time	Method
UPDRS;Berg balance scale;MMSE;MoCA;SDS;SAS